JANE STREET GROUP, LLC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 28 filers reported holding BRIACELL THERAPEUTICS CORP in Q2 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q3 2022$546,000
+88.3%
97,092
+93.1%
0.00%
Q2 2022$290,000
-64.5%
50,284
-37.6%
0.00%
Q1 2022$817,000
-62.7%
80,600
-69.6%
0.00%
-100.0%
Q4 2021$2,191,000
+668.8%
264,700
+651.3%
0.00%
Q3 2021$285,00035,2320.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 1,198,000$6,733,0007.35%
K.J. Harrison & Partners Inc 479,838$2,748,0000.97%
SABBY MANAGEMENT, LLC 94,005$528,0000.67%
Redmond Asset Management, LLC 137,689$774,0000.29%
Concord Wealth Partners 17,775$100,0000.03%
Virtu Financial LLC 48,347$272,0000.02%
Caption Management, LLC 177,000$996,0000.01%
WASATCH ADVISORS LP 353,744$1,988,0000.01%
Summit Trail Advisors, LLC 35,000$197,0000.01%
BLUEFIN CAPITAL MANAGEMENT, LLC 17,546$99,0000.01%
View complete list of BRIACELL THERAPEUTICS CORP shareholders